Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/macrophage-migration-inhibitory-factor-covalently-complexed-with-O38AGKx3ad
References (30)
-
Murshudov (2011)
355Acta Cryst. D, 67
-
E. Rosengren, R. Bucala, P. Åman, L. Jacobsson, G. Odh, C. Metz, H. Rorsman (1996)
The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization ReactionMolecular Medicine, 2
-
Ram Seshadri (2004)
Crystal structures -
A. Zernecke, J. Bernhagen, C. Weber (2008)
Macrophage Migration Inhibitory Factor in Cardiovascular DiseaseCirculation, 117
-
K. Brown, M. Hampton (2011)
Biological targets of isothiocyanates.Biochimica et biophysica acta, 1810 9
-
T. Calandra, B. Echtenacher, D. Roy, J. Pugin, C. Metz, L. Hültner, D. Heumann, D. Männel, R. Bucala, M. Glauser (2000)
Protection from septic shock by neutralization of macrophage migration inhibitory factorNature Medicine, 6
-
Zachary Healy, Hua Liu, W. Holtzclaw, P. Talalay (2011)
Inactivation of Tautomerase Activity of Macrophage Migration Inhibitory Factor by Sulforaphane: a Potential Biomarker for Anti-inflammatory InterventionCancer Epidemiology, Biomarkers & Prevention, 20
-
B. Holst, G. Williamson (2004)
A critical review of the bioavailability of glucosinolates and related compounds.Natural product reports, 21 3
-
S. Stamps, M. Fitzgerald, C. Whitman (1998)
Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor.Biochemistry, 37 28
-
Ouertatani-Sakouhi (2009)
9858Biochemistry, 48
-
P. Emsley, B. Lohkamp, William Scott, K. Cowtan (2010)
Features and development of CootActa Crystallographica Section D: Biological Crystallography, 66
-
I. Cvetković, Y. Al-Abed, D. Miljković, D. Maksimović‐Ivanić, J. Roth, M. Bacher, H. Lan, F. Nicoletti, S. Stošić-Grujičić (2005)
Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.Endocrinology, 146 7
-
B. Halkier, J. Gershenzon (2006)
Biology and biochemistry of glucosinolates.Annual review of plant biology, 57
-
M. Swope, Hong-Wei Sun, P. Blake, E. Lolis (1998)
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factorThe EMBO Journal, 17
-
J. Bernhagen, R. Mitchell, T. Calandra, W. Voelter, A. Cerami, R. Bucala (1994)
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).Biochemistry, 33 47
-
C. Bifulco, K. McDaniel, L. Leng, R. Bucala (2008)
Tumor growth-promoting properties of macrophage migration inhibitory factor.Current pharmaceutical design, 14 36
-
K. Brown, F. Blaikie, Robin Smith, J. Tyndall, H. Lue, J. Bernhagen, C. Winterbourn, M. Hampton (2009)
Direct Modification of the Proinflammatory Cytokine Macrophage Migration Inhibitory Factor by Dietary Isothiocyanates*The Journal of Biological Chemistry, 284
-
(2009)
Biochemistry, 48, 9858–9870 -
R. Kleemann, A. Hausser, Georg Geiger, R. Mischke, A. Burger-Kentischer, O. Flieger, F. Johannes, T. Roger, T. Calandra, A. Kapurniotu, M. Grell, D. Finkelmeier, H. Brunner, J. Bernhagen (2000)
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1Nature, 408
-
Y. Jong, A. Abadía-Molina, A. Satoskar, K. Clarke, S. Rietdijk, W. Faubion, E. Mizoguchi, C. Metz, M. Sahli, T. Hove, A. Keates, J. Lubetsky, R. Farrell, P. Michetti, S. Deventer, E. Lolis, J. David, A. Bhan, C. Terhorst (2001)
Development of chronic colitis is dependent on the cytokine MIFNature Immunology, 2
-
M. Winn, C. Ballard, K. Cowtan, E. Dodson, P. Emsley, P. Evans, R. Keegan, E. Krissinel, A. Leslie, A. Mccoy, S. McNicholas, G. Murshudov, N. Pannu, E. Potterton, H. Powell, R. Read, A. Vagin, K. Wilson (2011)
Overview of the CCP4 suite and current developmentsActa Crystallographica Section D: Biological Crystallography, 67
-
M. Leech, C. Metz, R. Bucala, E. Morand (2000)
Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis.Arthritis and rheumatism, 43 4
-
R. Hopkins, N. Dam, J. Loon (2009)
Role of glucosinolates in insect-plant relationships and multitrophic interactions.Annual review of entomology, 54
-
T. Calandra, T. Roger (2003)
Macrophage migration inhibitory factor: a regulator of innate immunityNature Reviews. Immunology, 3
-
L. Leng, C. Metz, Yan Fang, Jing Xu, S. Donnelly, J. Baugh, T. Delohery, Yibang Chen, R. Mitchell, R. Bucala (2003)
MIF Signal Transduction Initiated by Binding to CD74The Journal of Experimental Medicine, 197
-
Haiyoung Jung, Taenam Kim, H. Chae, Kyong-Tai Kim, Hyun-Mo Ha (2001)
Regulation of Macrophage Migration Inhibitory Factor and Thiol-specific Antioxidant Protein PAG by Direct Interaction*The Journal of Biological Chemistry, 276
-
Y. Al-Abed, S. VanPatten (2011)
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.Future medicinal chemistry, 3 1
-
J. Cross, Joshua Rady, F. Foss, C. Lyons, T. Macdonald, D. Templeton (2009)
Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF).The Biochemical journal, 423 3
-
L. McLean, Ying Zhang, Hua Li, Y. Choi, Zuoning Han, Roy Vaz, Yi Li (2010)
Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.Bioorganic & medicinal chemistry letters, 20 6
-
Mamoru Suzuki, H. Sugimoto, A. Nakagawa, I. Tanaka, J. Nishihira†, M. Sakai (1996)
Crystal structure of the macrophage migration inhibitory factor from rat liverNature Structural Biology, 3
- Publisher
- Wiley
- Copyright
- International Union of Crystallography, 2012
- ISSN
- 1744-3091
- eISSN
- 1744-3091
- DOI
- 10.1107/S1744309112030552
- pmid
- 22949182
- Publisher site
- See Article on Publisher Site
Abstract
Macrophage migration inhibitory factor is irreversibly inhibited via covalent modification by phenethyl isothiocyanate, a naturally occurring compound with anti‐inflammatory and anticancer properties. The structure of the modified protein obtained from X‐ray diffraction data to 1.64 Å resolution is presented. The inhibitor sits within a deep hydrophobic pocket between subunits of the homotrimer and is highly ordered. The secondary structure of macrophage migratory inhibitory factor is unchanged by this modification, but there are significant rearrangements, including of the side‐chain position of Tyr37 and the main chain of residues 31–34. These changes may explain the decreased binding of the modified protein to the receptor CD74. Together with the pocket, the areas of conformational change define specific targets for the design of more selective and potent inhibitors as potential therapeutics.
Journal
Acta Crystallographica Section F – Wiley
Published: Sep 1, 2012